Research never stops

Top Story

Evotec AG reports results of first half of 2016

Hamburg, Germany, 10 August 2016: Evotec AG today reported financial results and corporate updates for the first half of 2016.

- read more

Evotec achieves clinical development milestone as part of its multi-target alliance with Bayer in endometriosis

Hamburg, Germany, 04 August 2016: Evotec AG announced today that it has reached a milestone from Bayer for the progression of a programme from the alliance portfolio into Phase I clinical development for the treatment of endometriosis, triggering a milestone payment to Evotec.

- read more

Evotec AG increases its profitability guidance for 2016

Hamburg, Germany, 19 July 2016: Evotec AG today announced that, in the context of the half year results published on 10 August 2016, it increases its financial guidance for the current year.

- read more
loading weather report
Loading weather report...


Aug 30, 2016 - Preclinical and Translational Immuno-Oncology

Sep 19, 2016 - 5th German Corporate Conference, Berenberg/Goldman Sachs

Company Presentation August

Building integrated and high-value drug discovery alliances
2016-08_Evotec_Company presentation_August